Table 5.
Cox regression model to predict tumor overall survival, FAS population (n = 502).
Univariate Analysis | Hazard Ratio | 95% CI | p-Value |
High- vs. intermediate-risk group | 1.572 | 0.967–2.557 | 0.0679 |
T1 vs. Ta | 1.64 | 0.99–2.715 | 0.1579 |
Primary cis vs. T1 | 0 | 0 | |
Primary cis vs. Ta | 0 | 0 | |
G2 vs. G1 | 1.801 | 0.935–3.46 | 0.0533 |
G3 vs. G2 | 1.228 | 0.712–2.118 | |
G3 vs. G1 | 2.212 | 1.158–4.219 | |
Cis vs. no cis | 1.2 | 0.375–3.831 | 0.7571 |
Recurrent vs. primary | 1.017 | 0.618–1.675 | 0.947 |
Treatment duration <4 vs. ≥4 months | 1.948 | 1.171–3.239 | 0.0102 |
No maintenance vs. maintenance | 1.789 | 0.984–3.253 | 0.0565 |
Previous MMC vs. no | 0.967 | 0.461–2.024 | 0.9294 |
Previous BCG vs. no | 0.801 | 0.29–2.217 | 0.6709 |
Age ≥70 vs. <70 years | 3.459 | 1.943–6.157 | <0.0001 |
Male vs. female | 1.663 | 0.793–3.496 | 0.1781 |
Smoker vs. non-smoker | 0.973 | 0.506–1.869 | 0.9353 |
Multiple vs. single tumor | 1.158 | 0.591–2.269 | 0.6684 |
Size ≥3 vs. <3 cm | 1.024 | 0.724–1.449 | 0.8895 |
Multivariate Analysis | Hazard Ratio | 95% CI | p-value |
Age ≥70 vs. <70 years | 3.356 | 1.884–5.976 | <0.0001 |
Treatment duration <4 vs. ≥4 months | 1.824 | 1.095–3.039 | 0.0211 |